Deguchi Tsuneo, Kouno Yousuke, Terasaki Tetsuya, Takadate Akira, Otagiri Masaki
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan.
Pharm Res. 2005 Apr;22(4):619-27. doi: 10.1007/s11095-005-2486-x. Epub 2005 Apr 7.
Evidence suggests that uremic toxins such as hippurate (HA), indoleacetate (IA), indoxyl sulfate (IS), and 3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) promote the progression of renal failure by damaging tubular cells via rat organic anion transporter 1 (rOat1) and rOat3 on the basolateral membrane of the proximal tubules. The purpose of the current study is to evaluate the in vivo transport mechanism responsible for their renal uptake.
We investigated the uremic toxins transport mechanism using the abdominal aorta injection technique [i.e., kidney uptake index (KUI) method], assuming minimal mixing of the bolus with serum protein from circulating serum.
Maximum mixing was estimated to be 5.8% of rat serum by measuring estrone sulfate extraction after addition of 0-90% rat serum to the arterial injection solution. Saturable renal uptake of p-aminohippurate (PAH, K(m) = 408 microM) and benzylpenicillin (PCG, K(m) = 346 microM) was observed, respectively. The uptake of PAH and PCG was inhibited in a dose-dependent manner by unlabeled PCG (IC(50) = 47.3 mM) and PAH (IC(50) = 512 microM), respectively, suggesting that different transporters are responsible for their uptake. A number of uremic toxins inhibited the renal uptake of PAH and PCG. Excess PAH, which could inhibit rOat1 and rOat3, completely inhibited the saturable uptake of IA, IS, and CMPF by the kidney, and by 85% for HA uptake. PCG inhibited the total saturable uptake of HA, IA, IS, and CMPF by 10%, 10%, 45%, and 65%, respectively, at the concentration selective for rOat3.
rOat1 could be the primary mediator of the renal uptake of HA and IA, accounting for approximately 75% and 90% of their transport, respectively. rOat1 and rOat3 contributed equally to the renal uptake of IS. rOat3 could account for about 65% of the uptake of CMPF under in vivo physiologic conditions. These results suggest that rOat1 and rOat3 play an important role in the renal uptake of uremic toxins and the induction of their nephrotoxicity.
有证据表明,尿毒症毒素如马尿酸盐(HA)、吲哚乙酸(IA)、硫酸吲哚酚(IS)和3-羧基-4-甲基-5-丙基-2-呋喃丙酸(CMPF)通过近端肾小管基底外侧膜上的大鼠有机阴离子转运体1(rOat1)和rOat3损伤肾小管细胞,从而促进肾衰竭进展。本研究的目的是评估负责其肾脏摄取的体内转运机制。
我们采用腹主动脉注射技术[即肾脏摄取指数(KUI)法]研究尿毒症毒素的转运机制,假定推注物与循环血清中的血清蛋白混合最少。
通过向动脉注射溶液中添加0 - 90%的大鼠血清后测量硫酸雌酮提取率,估计最大混合量为大鼠血清的5.8%。分别观察到对氨基马尿酸(PAH,K(m)=408 microM)和苄青霉素(PCG,K(m)=346 microM)的可饱和肾脏摄取。未标记的PCG(IC(50)=47.3 mM)和PAH(IC(50)=512 microM)分别以剂量依赖性方式抑制PAH和PCG的摄取,表明不同的转运体负责它们的摄取。多种尿毒症毒素抑制PAH和PCG的肾脏摄取。过量的PAH可抑制rOat1和rOat3,它完全抑制了肾脏对IA、IS和CMPF的可饱和摄取,对HA摄取的抑制率为85%。在对rOat3有选择性的浓度下,PCG分别将HA、IA、IS和CMPF的总可饱和摄取抑制了10%、10%、45%和65%。
rOat1可能是HA和IA肾脏摄取的主要介导因子,分别占其转运的约75%和90%。rOat1和rOat3对IS的肾脏摄取贡献相同。在体内生理条件下,rOat3可能占CMPF摄取的约65%。这些结果表明,rOat1和rOat3在尿毒症毒素的肾脏摄取及其肾毒性诱导中起重要作用。